Rupert D'Souza - May 13, 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Financial Officer
Signature
Rupert D'Souza, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
ADVM
Transactions as of
May 13, 2022
Transactions value $
$16,857
Form type
4
Date filed
5/17/2022, 06:28 PM
Previous filing
Dec 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $8.59K +10K +1176.47% $0.86 10.9K May 13, 2022 Direct F1
transaction ADVM Common Stock Purchase $8.27K +10K +92.17% $0.83 20.9K May 17, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.856 to $0.865. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F2 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.8245 to $0.828. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.